ArticleBMC medical imaging2026
MSTM-Net: a two-stage prostate cancer segmentation network based on swin-transformer-mamba architecture.
Article in BMC medical imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMagnetic resonance imaging (MRI) has become a core imaging modality for prostate cancer screening and diagnosis. Accurate and automatic segmentation of lesion regions is critical for subsequent staging assessment and treatment planning.
methodsTo this end, this research proposes a two-stage segmentation framework for multimodal MRI. In the first stage, the prostate gland is segmented to extract the region of interest (ROI), thereby removing complex pelvic background structures. In the second stage, fine-grained prostate cancer lesion segmentation is performed within the ROI, enabling the model to focus on anatomically plausible lesion regions.A segmentation network, termed MSTM-Net, is developed based on this framework. The network adopts a Swin Transformer-based decoder architecture. At the input stage, T2-weighted images and apparent diffusion coefficient (ADC) maps are spatially aligned and concatenated along the channel dimension. During decoding, a Mamba module based on state-space modeling is introduced to jointly capture local structural information and long-range dependencies. Multi-head attention fusion and multi-scale feature fusion are further integrated into the skip connections to enhance the consistency between shallow spatial details and deep semantic representations.
resultsExperiments conducted on the cleaned PROSTATEx dataset demonstrate that the proposed method achieves a Dice score of 95.38% for prostate gland segmentation and 63.89% for lesion segmentation, outperforming the best comparative network by approximately 4% points, with an mIoU of 61.32%. Furthermore, cross-dataset validation on the PI-CAI dataset yields a Dice score of 63.14%, indicating good generalization ability and clinical feasibility for automated prostate cancer segmentation.
conclusionThe proposed MSTM-Net demonstrates effective performance for prostate cancer segmentation in multimodal MRI, achieving improved accuracy and feature representation compared with existing methods. The results indicate that the two-stage framework combined with multi-modal fusion and state-space modeling is a promising approach, although further validation on larger and more diverse datasets is required to enhance robustness and generalization.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.